ES8505546A1 - Un metodo para preparar una solucion acuosa estable que contiene factor de necrosis de tumores. - Google Patents

Un metodo para preparar una solucion acuosa estable que contiene factor de necrosis de tumores.

Info

Publication number
ES8505546A1
ES8505546A1 ES521266A ES521266A ES8505546A1 ES 8505546 A1 ES8505546 A1 ES 8505546A1 ES 521266 A ES521266 A ES 521266A ES 521266 A ES521266 A ES 521266A ES 8505546 A1 ES8505546 A1 ES 8505546A1
Authority
ES
Spain
Prior art keywords
aqueous solution
factor
powder containing
tumor necrosis
stable aqueous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES521266A
Other languages
English (en)
Other versions
ES521266A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26397663&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8505546(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP57056690A external-priority patent/JPS58174330A/ja
Priority claimed from JP57129560A external-priority patent/JPS5920225A/ja
Application filed by Asahi Chemical Industry Co Ltd, Asahi Kasei Kogyo KK filed Critical Asahi Chemical Industry Co Ltd
Publication of ES8505546A1 publication Critical patent/ES8505546A1/es
Publication of ES521266A0 publication Critical patent/ES521266A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

UN METODO PARA PREPARAR UNA SOLUCION ACUOSA ESTABLE QUE CONTIENE FACTOR DE NECROSIS DE TUMORES (FNT).COMPRENDE AN/ADIR AL MENOS UN MIEMBRO SELECCIONADO DEL GRUPO CONSTITUIDO POR UNA ALBUMINA, UNA GELATINA, UNA GLOBULINA, UNA PROTAMINA Y UNA SAL DE PROTAMINA A UNA SOLUCION ACUOSA DE POLVO QUE CONTIENE FNT. LA SOLUCION ACUOSA QUE CONTIENE FNT PUEDE ALMACENARSE DURANTE UN PERIODO PROLONGADO DE TIEMPO SIN PERDER SU ACTIVIDAD Y ES ESTABLE FRENTE A LA CONGELACION, DESCONGELACION, LIOFILIZACION, ETC.
ES521266A 1982-04-07 1983-04-06 Un metodo para preparar una solucion acuosa estable que contiene factor de necrosis de tumores. Granted ES521266A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP57056690A JPS58174330A (ja) 1982-04-07 1982-04-07 ガン壊死因子の安定化法
JP57129560A JPS5920225A (ja) 1982-07-27 1982-07-27 ガン壊死因子の安定化方法

Publications (2)

Publication Number Publication Date
ES8505546A1 true ES8505546A1 (es) 1985-06-01
ES521266A0 ES521266A0 (es) 1985-06-01

Family

ID=26397663

Family Applications (1)

Application Number Title Priority Date Filing Date
ES521266A Granted ES521266A0 (es) 1982-04-07 1983-04-06 Un metodo para preparar una solucion acuosa estable que contiene factor de necrosis de tumores.

Country Status (10)

Country Link
US (1) US4447355A (es)
EP (1) EP0091258B2 (es)
KR (1) KR860000842B1 (es)
CA (1) CA1187412A (es)
CH (1) CH656534A5 (es)
DE (1) DE3373628D1 (es)
ES (1) ES521266A0 (es)
FR (1) FR2530472B1 (es)
HU (1) HU189251B (es)
IT (1) IT1162845B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019719A (ja) * 1983-07-15 1985-01-31 Asahi Chem Ind Co Ltd 抗腫瘍活性を有する蛋白質
US4524026A (en) * 1983-08-29 1985-06-18 Yoshio Sakagami Novel proteinous cancer-cell proliferation inhibitory factors
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
DE3583880D1 (de) * 1984-04-09 1991-10-02 Takeda Chemical Industries Ltd Stabile interleukin-2-zusammensetzung.
JPS60260522A (ja) 1984-06-07 1985-12-23 Asahi Chem Ind Co Ltd 遺伝子組換体が生産する生理活性物質の安定化法
US5672347A (en) * 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
US6686455B1 (en) 1984-07-05 2004-02-03 Genentech, Inc. Tumor necrosis factor
US5840522A (en) * 1984-09-20 1998-11-24 Chiron Corporation Recombinant lectins
US4677063A (en) * 1985-05-02 1987-06-30 Cetus Corporation Human tumor necrosis factor
US4677064A (en) * 1984-11-09 1987-06-30 Cetus Corporation Human tumor necrosis factor
EP0216934A4 (en) * 1985-03-04 1987-07-09 Sawai Seiyaku Kk NOVEL SUBSTANCE INDUCING TUMOR NECROSIC FACTOR FROM ACID RESISTANT BACTERIA.
US6084073A (en) * 1985-03-25 2000-07-04 Chiron Corporation Recombinant ricin toxin
US4770995A (en) * 1985-08-29 1988-09-13 New York Blood Center, Inc Detection of the sensitivity of cells to the effects of tumor necrosis factor and lymphotoxin
US4870163A (en) * 1985-08-29 1989-09-26 New York Blood Center, Inc. Preparation of pure human tumor necrosis factor and hybridomas producing monoclonal antibodies to human tumor necrosis factor
US5425940A (en) * 1986-04-09 1995-06-20 Cetus Oncology Corporation Combination therapy using interleukin-2 and tumor necrosis factor
DE3631413A1 (de) * 1986-09-16 1988-03-24 Knoll Ag Therapeutisches system zur lokalen applikation von pharmawirkstoffen
US5215743A (en) * 1988-04-13 1993-06-01 Maninder Singh Tumor necrosis factor formulations
DE3839639A1 (de) * 1988-11-24 1990-05-31 Basf Ag Verwendung von tnf bei der behandlung von hautkrankheiten
US5223395A (en) * 1988-12-01 1993-06-29 Centocor, Inc. Immunometric assays for tumor necrosis factor-alpha and methods for preventing the loss of biological activity of tumor necrosis factor-alpha in biological samples
US5653974A (en) * 1990-10-18 1997-08-05 Board Of Regents,The University Of Texas System Preparation and characterization of liposomal formulations of tumor necrosis factor
EP0495187B1 (en) * 1991-01-15 1997-01-22 Hemosphere, Inc. Protein nanomatrixes and method of production
US5344644A (en) * 1991-08-01 1994-09-06 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release
DE4239877C1 (de) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung
JPH0776527A (ja) * 1993-06-28 1995-03-20 Hayashibara Biochem Lab Inc 半固形製剤とその製造方法
US5556771A (en) * 1995-02-10 1996-09-17 Gen-Probe Incorporated Stabilized compositions of reverse transcriptase and RNA polymerase for nucleic acid amplification
ES2180416B1 (es) 2001-03-12 2004-06-01 BIOTOOLS BIOTECHNOLOGICAL & MEDICAL LABORATORIES, S.A. Procedimiento para la preparacion de mezclas de reaccion estabilizadas, total o parcialmente desecadas, que comprenden, al menos, una enzima, mezclas de reaccion y kits que las contienen.
RU2377253C2 (ru) * 2002-12-02 2009-12-27 Амген Фремонт,Инк. Антитела, специфичные к фактору некроза опухолей, и их применение
JP2010143860A (ja) * 2008-12-19 2010-07-01 Chisso Corp タンパク質の安定化剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637640A (en) * 1970-05-04 1972-01-25 Diagnostic Data Inc Orgotein stabilized with saccharide process and products
JPS5668607A (en) * 1979-11-07 1981-06-09 Teikoku Hormone Mfg Co Ltd Medical preparation with storage stability

Also Published As

Publication number Publication date
EP0091258B1 (en) 1987-09-16
KR860000842B1 (ko) 1986-07-09
HU189251B (en) 1986-06-30
IT1162845B (it) 1987-04-01
EP0091258A3 (en) 1984-09-19
US4447355A (en) 1984-05-08
FR2530472A1 (fr) 1984-01-27
CA1187412A (en) 1985-05-21
KR840004365A (ko) 1984-10-15
FR2530472B1 (fr) 1986-04-25
IT8367372A0 (it) 1983-04-05
EP0091258B2 (en) 1992-12-16
ES521266A0 (es) 1985-06-01
DE3373628D1 (en) 1987-10-22
EP0091258A2 (en) 1983-10-12
CH656534A5 (fr) 1986-07-15

Similar Documents

Publication Publication Date Title
ES8505546A1 (es) Un metodo para preparar una solucion acuosa estable que contiene factor de necrosis de tumores.
ES8603271A1 (es) Un metodo de producir una composicion de interleuquina-2
ES8706446A1 (es) Un metodo para preparar una solucion acuosa estable que contiene factor de necrosis de tumores.
NZ227788A (en) Peptide having growth hormone regulatory effects, and compositions
ATE84707T1 (de) Implantate mit verzoegerter abgabe fuer die anwendung von rekombinanten wachstumshormonen.
EP0600532A3 (en) Use of ionic cloud point modifiers to prevent particle aggregation during sterilization.
ATE153648T1 (de) Verwendungen von alpha-hydroxyfettsäuren
ATE187646T1 (de) Verwendung von kupfer enthaltenden wirkstoffen zur beschleunigung der wundheilung
ES2009704A6 (es) Preservacion de virus.
DE2962569D1 (en) Immune serum globulin preparations and method to produce them
GR3005040T3 (es)
DE3571552D1 (en) Preparation containing stabilized polypeptide having gamma-interferon activity
DE3782117D1 (de) Verkapselung von trh bzw. dessen analoga.
EP0027573A3 (en) Method of stabilizing interferon and composition containing it
DK338888A (da) Fremgangsmaade til stabilisering af humane leukocyter, isaer granulocyter
ES2038733T3 (es) Procedimiento para preparar una solucion inyectable de la sal de acido tioctico con trometanol y/o aminoacidos basicos.
GB2014043A (en) Injectable embolization and occlusion solutions
AU564269B2 (en) Compositions containing s-adenosyl-l methionine
DE58903876D1 (de) Riboflavin-4'5'-cyclo-phosphorsaeureesterchlorid, dessen herstellung und verwendung zur herstellung von riboflavin-5'-phosphat (5'-fmn) bzw. dessen natriumsalz.
ATE84548T1 (de) Expression in e.coli von hybridpolypeptiden, die die sequenz des wachstumshormons ausloesenden faktors enthalten.
JPS57200359A (en) Lysine salt of 5-(p-chlorobenzoyl)-1,4-dimethyl- pyrrole-2-acetic acid, manufacture and medicine containing same
ATE15604T1 (de) Biostimulierendes mittel.
ES2005159A6 (es) Procedimiento para diagnostico y seguimiento de hepatopatias mediante determinacion de factor de crecimiento hepatico en plasma yno suero sanguineo.
Kozarić et al. Effect of acidosis on the histochemical activity of some enzymes in the mouse placenta
AU2530884A (en) Organic amino salt of an acid, manufacture and use as accelerator

Legal Events

Date Code Title Description
PC2A Transfer of patent

Free format text: DAINIPPON PHARMACEUTICAL CO, LTD.(TITULAR AL 50%)